A2B receptor antagonist 1

CAS No. 531506-36-2

A2B receptor antagonist 1( —— )

Catalog No. M32740 CAS No. 531506-36-2

A2B receptor antagonist 1 (EXAMPLE 9B) is a potent A2B adenosine receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 844 In Stock
5MG 735 In Stock
10MG 938 In Stock
25MG 1473 In Stock
50MG 1841 In Stock
100MG 2613 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    A2B receptor antagonist 1
  • Note
    Research use only, not for human use.
  • Brief Description
    A2B receptor antagonist 1 (EXAMPLE 9B) is a potent A2B adenosine receptor antagonist.
  • Description
    A2B receptor antagonist 1 is a potent A2B adenosine receptor antagonist extracted from patent WO 2009157938 A1 EXAMPLE 9B.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adenosine Receptor
  • Recptor
    Adenosine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    531506-36-2
  • Formula Weight
    392.45
  • Molecular Formula
    C21H24N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CC)N1C2=C(NC(=N2)C3=CN(CC4=CC=CC=C4)N=C3)C(=O)N(CCC)C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Rao Kalla, et al. A2b adenosine receptor antagonists for treating cancer. WO 2009157938 A1.
molnova catalog
related products
  • Trabodenoson

    Trabodenoson (INO-8875) is a selective and potent adenosine A1 receptor agonist, an adenosine analog, for the study of primary open-angle glaucoma.

  • AZD-4635

    AZD-4635 (HTL 1071) is a potent, selective and orally available adenosine 2A receptor (A2AR) inhibitor with Ki of 1.7 nM.

  • Evodenoson

    Evodenoson (ATL313) is a potent and selective adenosine A2a receptor (A2aR) agonist for the treatment of eye diseases, tumors, and immune system disorders, and may be used in studies of open-angle glaucoma and blood tumors.